METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS

    公开(公告)号:EP4248958A2

    公开(公告)日:2023-09-27

    申请号:EP23191736.0

    申请日:2022-01-27

    IPC分类号: A61K31/13

    摘要: The present invention relates to S1P receptor modulators, preferably mocravimod, for use in treating patients suffering from acute myelogenous leukemia (AML) and who have undergone allogeneic hematopoietic stem cell transplantation (HSCT). The invention relates in particular to methods of treating AML in subjects undergoing HSCT, wherein said method comprises daily administering an efficient amount of S1P receptor modulator, preferably mocravimod, to said subject in need thereof, for at least 6 months, preferably at least 12 months.